XOMA Royalty Corporation (XOMA) Stock Analysis

XOMA Royalty (XOMA) Stock Fair Value Falls After Ligand Agrees Cash Acquisition

Sat, June 27, 2026 at 5:07 PM UTC 2 min read

XOMA Royalty (XOMA) experienced a decline in its stock fair value following Ligand Pharmaceuticals' announcement of a cash acquisition deal. This development is significant for investors as it may impact XOMA's revenue streams and overall market position, raising concerns about the company's future growth prospects. Investors should closely monitor how this acquisition affects XOMA's financial health and strategic direction moving forward.

Read full article →

XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date

Fri, June 12, 2026 at 8:05 PM UTC 3 min read

XOMA Royalty Corporation has declared its quarterly preferred stock dividend and announced the redemption of its perpetual preferred stock. This move is significant for investors as it demonstrates the company's commitment to returning value to shareholders while simplifying its capital structure. Additionally, the announcement of the CVR dividend record date indicates potential future payouts, which could enhance investor confidence in XOMA's financial stability.

Read full article →